Collegium Pharmaceutical Inc (NASDAQ:COLL)
| 25.62 Delayed Data As of 3:59pm ET |  -0.01 / -0.04%Today’s Change | 20.83 Today|||52-Week Range 30.22 | +10.43% Year-to-Date |
Latest COLL News | Press Releases
| Insider Sell: EVP and General Counsel Shirley Kuhlmann Sells 25,600 Shares of Collegium ... Nov 30 / GuruFocus News - Paid Partner Content |
Today’s Trading
| Previous close | 25.63 |
| Today’s open | 25.64 |
| Day’s range | 25.51 - 25.97 |
| Volume | 10,701 |
| Average volume (3 months) | 319,104 |
| Market cap | $854.4M |
Data as of 3:59pm ET, 12/01/2023
Growth & Valuation
| Earnings growth (last year) | -136.11% |
| Earnings growth (this year) | +32.37% |
| Earnings growth (next 5 years) | +42.00% |
| Revenue growth (last year) | +67.56% |
| P/E ratio | 106.8 |
| Price/Sales | 1.69 |
| Price/Book | 4.55 |
Competitors
| ---- |
| ---- |
| ---- |
| ---- |
Data as of 12/30/1899
Financials
| Next reporting date | February 22, 2024 |
| EPS forecast (this quarter) | $1.45 |
| Annual revenue (last year) | $463.9M |
| Annual profit (last year) | -$25.0M |
| Net profit margin | -5.39% |
Profile
Sector Health Technology |
Industry Pharmaceuticals: Major |
No executives to display |
Corporate headquarters Stoughton, Massachusetts |
Forecasts
